The Lux Take on the Future of Digital Biomarkers

Digital biomarkers will impact healthcare within the next year and are key to the future of medicine

COVID-19, AGING DEMOGRAPHICS, & CHRONIC DISEASES ARE PUSHING DIGITAL BIOMARKERS FORWARD AS A CRITICAL ELEMENT OF THE $10 TRILLION GLOBAL HEALTH MARKET

While a lot of hype has surrounded digital biomarkers, in many cases, it is justified, as digital biomarkers hold the promise of underpinning both healthcare diagnostics and therapeutics.

In our newest report, “The Lux Take on the Future of Digital Biomarkers,” we assess digital biomarkers on five key factors to gauge their market readiness in the coming year.

Download the executive summary to learn more.


About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory services, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux empowers clients to make more informed decisions today to ensure future success.

For more information and insight from Lux Research, visit our blog, connect on LinkedIn, or follow @LuxResearch.

Download the Executive Summary